Prospective prevalence of pathologic gambling and medication association in Parkinson disease.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 16769956.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors prospectively screened 297 patients with Parkinson disease (PD), who attended a tertiary clinic, using a modified South Oaks Gambling Scale. Lifetime prevalence of pathologic gambling (PG) was 3.4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist.
Medical subject headings
- Antiparkinson Agents
- Dopamine Agents
- Gambling
- Levodopa
- Parkinson Disease
- Risk Assessment